Notable

At a glance

Pricing

Free / Custom

HIPAA

Attested

SOC 2

Type II

EHRs

2

Founded

2017

HQ

US

Bottom line

Healthcare-workflow AI platform: scribing, prior auth, patient outreach. Enterprise-focused.

Free tier available. HIPAA + SOC 2 Type II attested. integrates with Epic, Cerner.

Pricing

What it costs

Free tier only; no paid plans publicly disclosed.

Source: vendor pricing page. Verified May 23, 2026.

Compliance + integration

What deploys cleanly

Carries HIPAA, SOC2 per vendor documentation. Independent attestation review is the buyer's responsibility before clinical deployment. Integrates with 2 EHRs: Epic, Cerner.

Vendor stability

Who builds it

Notable (Notable Health Inc.) was founded in 2017 in US, putting it 9 years into market.

Peer-reviewed coverage

What the literature says

5 peer-reviewed studies indexed on PubMed evaluate Notable in clinical contexts. The most relevant are shown below, ranked by editorial relevance score combining title match, study design, recency, and journal tier.

Unveiling Genital Crohn's Disease: Clinical Complications, Diagnosis, and Treatment, a Comprehensive Review of Case Reports.

Fahim B, Elnaggar M, Ebrahim MA, et al.· Gastro Hep Adv· 2026Case Report

Genital Crohn's disease (GCD) is an infrequent extraintestinal manifestation of Crohn's disease characterized by ulceration, pain, edema, and erythema in the anogenital area. GCD poses significant diagnostic and management challenges, mainly because there are no standardized clinical protocols. This review analyzed 20 case reports and series from 1983 to 2024, focusing on patients with GCD. The databases used for this search were PubMed, Scopus, and Google Scholar. The most common presentation in male patients was genital edema or swelling, seen in 88.9% of cases. Pain was the main presentati…

Global Evolution and Phylodynamics of Coxsackievirus A4.

Han Z, Li J, Xiao J, et al.· J Med Virol· 2026

Coxsackievirus A4 (CVA4) is an enterovirus associated with diverse clinical syndromes, yet its global evolution and transmission dynamics remain poorly defined. This study aimed to characterize the molecular epidemiology, evolutionary history, and phylodynamic patterns of CVA4 at both local and global scales. In 2024, 34 CVA4 infections were identified during a localized herpangina outbreak in Beijing, primarily affecting children under 5 years of age, with a pronounced peak in July. High detection and isolation rates, together with temporal clustering in mid-2024, indicate a genuine short-te…

More Than a Tool: How Context Shapes the Implementation of Digital Diaries in the Intensive Care Unit.

Schol CMA, Ista E, van Son-Kemmeren W, et al.· Nurs Crit Care· 2026Observational

Despite the potential benefits of digital intensive care unit (ICU) diaries (e-diaries), their implementation remains challenging due to barriers such as workload, digital literacy and staff resistance. To explore the real-world, tailored implementation of an e-diary in adult ICUs. A multicentre, mixed methods study was conducted across the ICUs of four Dutch hospitals. The following outcomes were assessed: adoption and engagement, normalisation, fidelity of use and the implementation process. Data were collected through usage metrics, a questionnaire and semi-structured interviews with ICU n…

Research Progress on the Anticancer Activity of Natural Indole Alkaloids.

Zheng W, Zhang K, Fan X, et al.· Arch Pharm (Weinheim)· 2026

Cancer poses a devastating global threat, inflicting immense physical suffering, high mortality rates, severe psychological distress, and substantial economic burdens on individuals, families, and healthcare systems worldwide while gravely compromising quality of life and leaving long-lasting impacts on affected communities. As a fundamental and versatile modality for cancer treatment, chemotherapy exerts a pivotal effect in shrinking tumors, eliminating residual cancer cells, alleviating symptoms, and improving survival rates across various cancer types, whether utilized as monotherapy or in…

Postoperative nausea and vomiting as a predictor of chemotherapy-induced nausea and vomiting in gynecologic cancer: a retrospective cohort study.

Yamamoto S, Iihara H, Watanabe D, et al.· Support Care Cancer· 2026

Postoperative nausea and vomiting (PONV) and chemotherapy-induced nausea and vomiting (CINV) share multiple patient-related risk factors, suggesting a common underlying emetogenic susceptibility. However, whether PONV serves as a clinically meaningful predictor of subsequent CINV remains unclear. This study aimed to determine whether the presence of PONV after gynecologic cancer surgery is associated with poorer CINV control during the first cycle of postoperative paclitaxel plus carboplatin chemotherapy. We conducted a single-center retrospective cohort study in women with gynecologic malign…

See all on PubMed